Future treatment of patients with HCV cirrhosis
Author:
Affiliation:
1. Department of Hepato-Gastroenterology; Hospital Saint Joseph; Marseille; France
2. Department of Hepato-Gastroenterology; Saint Luc University Hospital; Montréal; Canada
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2011.02702.x/fullpdf
Reference37 articles.
1. Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study;Bruno;Hepatology,2010
2. Pegylated interferon-a2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007);Bourliere;Antivir Ther,2011
3. A review of the treatment of chronic hepatitis C virus infection in cirrhosis;Vezali;Clin Ther,2010
4. Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP);Fattovich;J Hepatol,1997
5. Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatment;Valla;Hepatology,1999
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Daclatasvir and asunaprevir treatment in patients with severe liver fibrosis by hepatitis C virus genotype 1b infection: Real-world data;Journal of Gastroenterology and Hepatology;2017-10-10
2. Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice;Archives of Virology;2017-10-05
3. Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study;Clinical and Molecular Hepatology;2017-03-25
4. Is stronger better in curing hepatitis C virus infection?;Annals of Translational Medicine;2016-10
5. Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection;Clinical and Molecular Hepatology;2016-06-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3